img

340B Report’s Expert Tip series includes valuable tips from our impressive roster of sponsors. The tips are intended to help 340B providers be more efficient, reduce costs, increase savings, and improve patient care. The tips are also another way for our readers to connect with and get to know our great sponsors. We encourage you to check out the tips below!


Expert Tip From PharmaForce

img
img

TIP: When approving your 340B wholesaler invoices for payment, make sure to compare the invoiced amount to your 340B catalog or the ceiling price to ensure you were not overcharged.


The problem:  Most covered entities have tens if not hundreds of invoices from multiple wholesalers and distributors on a monthly basis and often pay without ever questioning or verifying the amount charged. Often these invoices go to your accounting department and are approved for payment via the hospital’s or health center’s accounting software. We have seen a lot of instances where those invoices are incorrect (often inadvertently) leading to overpayment by the covered entity. As manufacturer restrictions and the removal of 340B pricing from wholesaler accounts has become more prevalent, we have found this as one of the leading reasons for errors on invoices.

The solution:  The covered entity can take steps to mitigate instances of overpayments by 1) understanding each distributors invoicing practices and timeline, 2) implement a process that reviews invoice reports on a regular basis that compares invoice pricing, 3) spot-check invoices. If the CE finds any instances of overpayments then it can report it to the wholesaler and seek remediation options. Additionally, entities are encouraged to report to HRSA instances where the 340B ceiling price is not offered.

Read More »

Expert Tip From Visante

img
img

TIP: For any covered entities with a contract pharmacy program, it is critical to review carve-out/ineligible claims data from your TPA system(s) to understand why claims are not qualifying in your 340B program.


Carved-out/ineligible claim data can reveal potential configuration issues or limitations within the TPA system.  Examples can include entity-owned pharmacies that have had manufacturer restrictions being applied, prescribers or locations that are 340B eligible but are not configured correctly, excluded payers that should be eligible or claims that were not reprocessed after manufacturer pricing was restored.

Read More »

Expert Tip From CPS

img
img

TIP: For sites submitting data to 340B ESP, the option exists within the 340B ESP portal to “Attest” for several manufacturers which will help to enable 340B pricing in advance of receiving any claims for these manufacturers.


To perform the attestation, you must be logged into your 340B ESP portal, and click the Entity Profile option in the menu. The “Make Attestations” button will be available under the following manufacturers: Bausch, Gilead, GSK, Johnson & Johnson, Novo Nordisk, and Sanofi. By clicking the “Make Attestations” button, you are attesting that you will submit transaction data for these manufacturers when the data becomes available. This action can be performed for each covered entity that you have registered in 340B ESP.

Read More »

Expert Tip From Cervey

img
img

TIP: Accurately tracking and loading drug prices into the ESP system can be the difference maker when it comes to maintaining compliance and ensuring maximum savings.


If you’re a covered entity who contracts with outside pharmacies, it’s important to start with the basics. Equip yourself with these tips to troubleshoot any price loading roadblocks you may encounter, and ensure pricing is loaded as quickly and efficiently as possible.

First, if pricing has not been loaded, it may cause a claim to be ineligible when using “winners only” logic. Be sure to send these ineligible claims to 340B ESP so pricing can be loaded. Second, the HIN number can be another problem area to watch out for. The HIN number is required by manufacturers for each contract pharmacy location. If there’s no HIN number, the manufacturer may forgo loading the price.

Lastly, different manufacturers have different policies and load prices based on varying criteria. For example, Eli Lilly and Pfizer claims must be uploaded on a store-by-store basis. Pricing is restored one contract pharmacy location at a time as a claim with one of their NDCs gets uploaded to 340B ESP. Know your manufacturer’s policy to avoid any hiccups!

Read More »

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live